Rheumatoid Arthritis

Learn more about rheumatoid arthritis

Rheumatoid Arthritis: Disease Overview

More than one in 100 Americans live with rheumatoid arthritis (RA). BRI was an early leader in understanding the genetic component of RA, and scientists at BRI continue their work to understand what causes it, how to prevent it, and how to better treat it.

Laboratory scientists are using tetramers — a tool, developed at BRI, that makes it possible to track the activity of specific T cells — to study the underlying cause of RA and develop targeted therapies. Translational scientists are investigating how environmental factors contribute to the development and exacerbation of RA. Clinical trials are underway comparing how well different drugs and drug combinations work in treating the disease.

What Is Rheumatoid Arthritis?

Rheumatoid arthritis (RA) is an autoimmune disease in which the body’s immune system mistakenly attacks the membrane that lines the joints (called the synovium) and causes fluid buildup that results in inflammation and pain. RA can also affect the skin, eyes, lungs, heart and blood vessels.

Almost 1% of adults in the United States live with this chronic disease, and women are three times more likely to have RA than men. Most people with RA experience intermittent periods of intense disease activity punctuated by periods of fewer symptoms or even remission. Over time, RA damages cartilage, bones and ligaments, and can lead to deformity of the joints and loss of mobility. Though RA can begin at any age, disease onset is most common in women between ages 30-60. It is rare in men under the age of 45. As many as 300,000 children in the U.S. have a distinct, but related, form of inflammatory arthritis known as juvenile idiopathic arthritis (formerly called juvenile rheumatoid arthritis).

What Causes Rheumatoid Arthritis?

Scientists don’t yet know exactly why the immune system mistakenly attacks the lining of the joints or what causes it to start. Researchers at BRI are investigating the interplay of genetics and environmental triggers to pinpoint why rheumatoid arthritis begins.

What Are Risk Factors for Rheumatoid Arthritis?

  • Sex – Women are nearly three times more likely to develop rheumatoid arthritis (RA) than men.
  • Age – RA typically begins during middle age (though it is possible to develop at any age).
  • Family history – having a close family member with RA, like a parent, sibling or child
  • Smoking
  • Excess weight

What Are the Signs and Symptoms of Rheumatoid Arthritis?

  • Pain, aching and/or stiffness in more than one joint (usually worse in the mornings and after inactivity)
  • Tenderness and swelling in more than one joint
  • The same symptoms on both sides of the body (such as in both hands or both knees)
  • Fatigue
  • Fever
  • Loss of appetite

Rheumatoid arthritis tends to affect the smaller joints first, such as the joints that connect your fingers to your hands and your toes to your feet.

What Is the Latest Research Into Rheumatoid Arthritis?

BRI was an early leader in understanding the genetic underpinnings of rheumatoid arthritis (RA). Today, our research includes:

Clinical studies

HIPC-RV Clinical Study

We are looking for adults with and without rheumatoid arthritis to join the Human Immunology Project Consortium - Respiratory Virus (HIPC-RV) clinical study to understand the immune response to upper respiratory infection (cold). Read More

Labs Studying Rheumatoid Arthritis and Rheumatic Diseases

Bettelli Lab Main

Bettelli Lab

The main focus of the Bettelli Lab is to identify the cell types of the immune system and mechanisms, which induce and regulate the development of autoimmunity.
View Lab
Buckner Lab Main

Buckner Lab

The Buckner Lab is focused on identifying the underlying mechanisms by which regulation of the adaptive immune response fails or is overcome in the setting of human autoimmunity. 
View Lab
Hamerman Lab Main

Hamerman Lab

The lab is interested in understanding how myeloid cells contribute to both productive and pathological immune responses during infection, inflammation, and autoimmune diseases.
View Lab
James Lab Main

James Lab

The James lab is working to develop an increasingly in depth knowledge of autoreactive T cell responses by examining the characteristics of the epitope specific cells involved in autoimmune diseases through robust multi-parameter assays and also at the single cell level.
View Lab
Mikacenic Lab Main

Mikacenic Lab

The Mikacenic lab is focused on understanding how lung immune cells contribute to inflammation, repair, and fibrosis.
View Lab

Are you living with rheumatoid arthritis?

Support rheumatoid arthritis research at BRI by participating in our rheumatic diseases biorepository.

Blog Stories

Blog Main Mikaela Horse Editorial
September 25, 2023

Participants Like Mikaela Fuel Research Advances

Participating in a clinical trial for type 1 diabetes (T1D) was easy for 9-year-old Mikaela. “Everyone was really nice. I just had to drink a milkshake with some medicine in it and get an IV.
Read Article
Blog Main Image - Clinician Woman Talking Patient Man Senior 2
March 14, 2023

Prediction and Prevention: A New Paradigm in Autoimmune Disease

The FDA recently approved teplizumab, a groundbreaking therapy that signals a paradigm shift in treating not only T1D but all autoimmune diseases.
Read Article
Dr. Buckner reviewing information
February 4, 2023

BRI's Vision of Immune Health

A message from BRI President Jane Buckner, MD, about BRI's new, broader vision for immune health.
Read Article

Immuno-what? Hear the latest from BRI

Keep up to date on our latest research, new clinical trials and exciting publications.